Evaluation of thieno[3,2-b]pyrrole[3,2-d]pyridazinones as activators of the tumor cell specific M2 isoform of pyruvate kinase

被引:96
作者
Jiang, Jian-kang [1 ]
Boxer, Matthew B. [1 ]
Vander Heiden, Matthew G. [2 ,3 ,4 ]
Shen, Min [1 ]
Skoumbourdis, Amanda P. [1 ]
Southall, Noel [1 ]
Veith, Henrike [1 ]
Leister, William [1 ]
Austin, Christopher P. [1 ]
Park, Hee Won [5 ,6 ]
Inglese, James [1 ]
Cantley, Lewis C. [3 ,7 ]
Auld, Douglas S. [1 ]
Thomas, Craig J. [1 ]
机构
[1] NHGRI, Chem Genom Ctr, NIH, Rockville, MD 20850 USA
[2] MIT, Robert Koch Inst, Cambridge, MA 02139 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA
[5] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L5, Canada
[6] Univ Toronto, Dept Pharmacol, Toronto, ON M5S 1A8, Canada
[7] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA
基金
英国惠康基金; 美国国家卫生研究院;
关键词
Warburg effect; Pyruvate kinase; Cellular metabolism; Anti-cancer strategies; Small molecule activators; CANCER CELLS; M-GENE; GROWTH; RAT; IDENTIFICATION; METABOLISM; INHIBITORS; ISOZYMES; HALIDES; M2-PK;
D O I
10.1016/j.bmcl.2010.04.015
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Cancer cells have distinct metabolic needs that are different from normal cells and can be exploited for development of anti-cancer therapeutics. Activation of the tumor specific M2 form of pyruvate kinase (PKM2) is a potential strategy for returning cancer cells to a metabolic state characteristic of normal cells. Here, we describe activators of PKM2 based upon a substituted thieno[3,2-b]pyrrole[3,2-d]pyridazinone scaffold. The synthesis of these agents, structure-activity relationships, analysis of activity at related targets (PKM1, PKR and PKL) and examination of aqueous solubility are investigated. These agents represent the second reported chemotype for activation of PKM2. Published by Elsevier Ltd.
引用
收藏
页码:3387 / 3393
页数:7
相关论文
共 50 条
  • [1] 2-Oxo-N-aryl-1,2,3,4-tetrahydroquinoline-6-sulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase
    Walsh, Martin J.
    Brimacombe, Kyle R.
    Veith, Henrike
    Bougie, James M.
    Daniel, Thomas
    Leister, William
    Cantley, Lewis C.
    Israelsen, William J.
    Vander Heiden, Matthew G.
    Shen, Min
    Auld, Douglas S.
    Thomas, Craig J.
    Boxer, Matthew B.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (21) : 6322 - 6327
  • [2] Evaluation of Substituted N,N′-Diarylsulfonamides as Activators of the Tumor Cell Specific M2 Isoform of Pyruvate Kinase
    Boxer, Matthew B.
    Jiang, Jian-kang
    Vander Heiden, Matthew G.
    Shen, Min
    Skoumbourdis, Amanda P.
    Southall, Noel
    Veith, Henrike
    Leister, William
    Austin, Christopher P.
    Park, Hee Won
    Inglese, James
    Cantley, Lewis C.
    Auld, Douglas S.
    Thomas, Craig J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (03) : 1048 - 1055
  • [3] 1-(sulfonyl)-5-(arylsulfonyl)indoline as activators of the tumor cell specific M2 isoform of pyruvate kinase
    Yacovan, Avihai
    Ozeri, Rachel
    Kehat, Tzofit
    Mirilashvili, Sima
    Sherman, Daniel
    Aizikovich, Alex
    Shitrit, Alina
    Ben-Zeev, Efrat
    Schutz, Nili
    Bohana-Kashtan, Osnat
    Konson, Alexander
    Behar, Vered
    Becker, Oren M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (20) : 6460 - 6468
  • [4] New Carboxamides of the Thieno[3,2-b]pyrrole Series
    Torosyan, S. A.
    Nuriakhmetova, Z. F.
    Gimalova, F. A.
    Miftakhov, M. S.
    RUSSIAN JOURNAL OF ORGANIC CHEMISTRY, 2020, 56 (10) : 1850 - 1853
  • [5] Convenient synthesis and anticancer evaluation of novel pyrazolyl-thiophene, thieno[3,2-b]pyridine, pyrazolo[3,4-d]thieno[3,2-b]pyridine and pyrano[2,3-d]thieno[3,2-b]pyridine derivatives
    Masaret, Ghada S.
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2021, 58 (06) : 1344 - 1358
  • [6] Synthesis and Anticancer Evaluation of Some Novel Thiophene, Thieno[3,2-d]pyrimidine, Thieno[3,2-b]pyridine, and Thieno[3,2-e][1,4]oxazepine Derivatives Containing Benzothiazole Moiety
    Hassan, Aisha Y.
    Husseiny, Ebtehal M.
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2019, 56 (09) : 2419 - 2429
  • [7] 4H-Thieno[3,2-b]pyrrole-5-carbohydrazides and Their Derivatives
    Torosyan, S. A.
    Nuriakhmetova, Z. F.
    Gimalova, F. A.
    Egorov, V. A.
    Miftakhov, M. S.
    RUSSIAN JOURNAL OF ORGANIC CHEMISTRY, 2020, 56 (09) : 1545 - 1549
  • [8] Trisubstituted Thieno[3,2-b]pyrrole 5-Carboxamides as Potent Inhibitors of Alphaviruses
    Ching, Kuan-Chieh
    Kam, Yiu-Wing
    Merits, Andres
    Ng, Lisa F. P.
    Chai, Christina L. L.
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (23) : 9196 - 9213
  • [9] New 4H-thieno[3,2-b]pyrrole-5-carboxamides
    Torosyan, Seda A.
    Nuriakhmetova, Zoya F.
    Zagitov, Vadim V.
    Gimalova, Fanusa A.
    Miftakhov, Mansur S.
    CHEMISTRY OF HETEROCYCLIC COMPOUNDS, 2018, 54 (08) : 819 - 822
  • [10] Synthesis and evaluation of thieno[3,2-d]pyrimidine derivatives as novel FMS inhibitors
    Kim, Yu-Yon
    Choi, Jaeyul
    Choi, Kyungjin
    Park, Changhee
    Kim, Young Hoon
    Suh, Kwee Hyun
    Ham, Young Jin
    Jang, Sun Young
    Lee, Kyu-Hang
    Hwang, Kwang Woo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (02) : 271 - 275